Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New web tool aims to ease tough surgery decisions for young breast cancer patients

NCT ID NCT06275126

First seen Oct 31, 2025 · Last updated Jun 20, 2026 · Updated 38 times

Summary

This study tests a web-based tool called CONSYDER to help young women (ages 18-44) with early-stage breast cancer make more informed decisions about their surgery. Participants use the tool before meeting their surgeon and complete surveys about their decision-making. The goal is to reduce confusion and improve communication with doctors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Duke Cancer Institute

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Yale Cancer Center

    RECRUITING

    New Haven, Connecticut, 06510, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CONSYDER decision aid (web-based tool)

What this could lead to

If successful, this tool could help young breast cancer patients feel more confident and informed when choosing their surgery.

What could go wrong

This is an early-stage study focused on decision-making, not a treatment. The tool may not improve outcomes for everyone, and results depend on patient engagement.

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma in situ breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.